当前位置: X-MOL 学术Thorac. Cancer › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Immune checkpoint inhibitors for first-line treatment of advanced non-small-cell lung cancer: A systematic review and network meta-analysis
Thoracic Cancer ( IF 2.3 ) Pub Date : 2021-09-20 , DOI: 10.1111/1759-7714.14148
Tzu-Rong Peng, Hung-Hong Lin, Fang-Pei Tsai, Ta-Wei Wu

Currently, several immune checkpoint inhibitors (ICIs) treatment for advanced non-small-cell lung cancer (NSCLC) have been investigated; their overall efficacy and safety remain unclear.

中文翻译:


免疫检查点抑制剂一线治疗晚期非小细胞肺癌:系统评价和网络荟萃分析



目前,已有多种免疫检查点抑制剂(ICIs)治疗晚期非小细胞肺癌(NSCLC)的研究;它们的总体功效和安全性仍不清楚。
更新日期:2021-11-03
down
wechat
bug